Investor · 1 deal
Every published round Clem Jones Group took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
| Company | Stage | Announced | Amount | Role | Alongside | Sources |
|---|---|---|---|---|---|---|
| Ceretas | Unnamed stage | Jul 2026 | $8m | Participant | Dealroom, kalkine.com.au, sharecafe.com.au |
Companies Clem Jones Group has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| Ceretas | Delivers personalised therapeutic ultrasound for Alzheimer's disease | Jul 2026 | 1 | 0 |
Fund closes reported for Clem Jones Group, as distinct from the investments it has made.
Companies Clem Jones Group has backed that another company then bought. An exit for the holding, not a deal Clem Jones Group did.
Stories naming Clem Jones Group. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
UQ medtech spin-out Ceretas sold its IPO, raising about $8 million, and now targets a fast-tracked ASX debut; the article also recalls ResApp's 2022 acquisition by Pfizer.
Also kalkine.com.au·Dealroom